ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/04/2023
Back to search
Official data from USPTO
RAXONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RAXONE
ST13
US500000097407005Class
1, 5, 42
Filing
97407005
Registration
7172934
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
10/04/2023
Trademark type
Word
Nice classes
1, 5, 42
Filing date
05/12/2022
Registration date
09/26/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
09/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
35
Owner location
PARMA, IT
Examiner
PARKER, JUSTINE D
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CHIESI FARMACEUTICI S.P.A.
Santhera Pharmaceuticals (Schweiz) AG
Representatives
Patrick J. Concannon NUTTER, MCCLENNEN & FISH, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemicals used in industry and science
Class 5
pharmaceuticalveterinary and sanitary preparationschemical preparations for use in the treatment of muscular dystrophymuscle wastingatrophyneuromuscular diseasescardiomyopathiesataxiasoptic nerve degradationneurological indications and memory loss
Class 42
computer programming for scientific and industrial research in the fields of cell culturesmuscular dystrophymuscle wastingatrophyneuromuscular diseasescardiomyopathiesataxiasoptic nerve degradationneurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseasesscientific research in the fields of muscular dystrophymuscle wastingatrophyneuromuscular diseasescardiomyopathiesataxiasoptic nerve degradationneurological indications and memory loss
Publications
History of USPTO decisions and trademark events.
20 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/26/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/24/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/02/2023
GNRT
NON-FINAL ACTION E-MAILED
03/02/2023
CNRT
NON-FINAL ACTION WRITTEN
03/02/2023
DOCK
ASSIGNED TO EXAMINER
03/02/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/30/2022
ALIE
ASSIGNED TO LIE
06/30/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/17/2022
NWAP
NEW APPLICATION ENTERED
05/16/2022
Continuous trademark protection
Get notified about every new filing that threatens RAXONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.